Solvandria Foundation

💡 Evolving Funding Landscape for U.S. Medtech Startups While venture capital still prioritizes established regions like the West and Northeast, today’s medtech startups face funding gaps in the early stages due to prolonged regulatory paths and complex reimbursement environments. However, innovative financing strategies, such as Special Purpose Acquisition Companies (SPACs) and strategic partnerships, create new opportunities to bridge these gaps and accelerate growth. 🌱 📊 Check our attachment for the latest MedTech investment trends, a few funding types, and a breakdown of the funding stages that support startup success. Stay tuned for more information from our knowledge-share series! Contributors - Iyappan Annamalai Subbiah, Malvika Verma Miller, Ph.D. #MedTech #MedTechFunding #MedTechInnovation #VCFunding #StartupGrowth

🌟 The MedTech landscape in Latin America is evolving rapidly, with digital health and telemedicine leading the way in transforming healthcare delivery across the region! 📲 With nearly 80% of the population connected to mobile networks, the potential for scaling health and medical technologies is enormous. 🏥🚀 Much of this growth is fueled by investments in research and development, alongside collaborations between governments, universities, and the private sector, fostering an ecosystem that accelerates innovation and accessibility in healthcare. 📈 In this week’s Knowledge Share series, we’ll dive into key MedTech hubs in Latin America, highlighting emerging startups and showcasing how strategic initiatives are bridging healthcare access and efficiency gaps. 🌍💡 Contributors - Iyappan Annamalai Subbiah, Malvika Verma Miller, Ph.D. Startups Highlighted - Neurobots, Entelai, Biva - Digital Patient Care, Granta, Sonicdrops #MedTech #Innovation #Healthcare #LatinAmerica #LATAM #MedTechStartups #MedicalDevice

The Fleming Initiative has achieved so much in the past 12 months, but there’s more work to be done in our global fight against antimicrobial resistance. Yesterday, we were delighted to announce LifeArc, Cepheid, and Optum as new partners that bring invaluable world-leading expertise across diagnostics, global health data, and research translation to the Initiative.  We are looking forward to building more innovative partnerships between researchers, industry, policy makers, and – most importantly – the public. This is only the beginning of our work. By founding programmes around the world – starting with the Fleming Centre in Paddington, London, on the site penicillin was discovered – the Fleming Initiative will spark real-world solutions that bring an end to this global threat. Watch our new video ⤵ https://lnkd.in/exneDJGg

🌟 The European MedTech landscape is thriving, boasting over 37,000 companies, 90% of which are small to medium enterprises! 🏢 MedTech accounts for 7.9% of total healthcare expenditure in Europe, with medical devices representing 7.2%. 💰 Much of this innovation stems from university research labs, as European nations prioritize R&D in their MedTech growth strategies. In this week’s Knowledge Share series, we’ll highlight key hubs of MedTech innovation across Europe, spotlighting promising startups and exploring how trends and government initiatives fuel progress in this dynamic sector. 💡🚀 Stay tuned for more insights into MedTech innovation from around the globe in the coming weeks! 🌍✨ Contributors - Iyappan Annamalai Subbiah, Malvika Verma Miller, Ph.D. Startups highlighted - inContAlert, Sonio, CoMind, D-Heart, Apersys AG #MedTech #Innovation #Healthcare #Europe #MedTechStartups #MedicalDevice

🌟 Exciting developments are unfolding in the Asian MedTech landscape! 🌟 By 2029, Asia’s Medical Technology market is projected to reach $194B, with Medical Devices leading the way. 🚀 Japan is making notable advances in robotics-assisted surgery, and the region is growing at a robust 6.44% CAGR. 📈 In this week’s Knowledge Share series, we explore key Asian hotspots for MedTech innovation, spotlighting standout startups and highlighting how government initiatives drive innovation and support these emerging technologies' growth. 💡 Stay tuned for more insights into MedTech innovation across various regions in the coming weeks! Contributors - Iyappan Annamalai Subbiah Malvika Verma Miller, Ph.D. Startups highlighted - EyRIS, Anaut, Promedius Inc., Dozee, Valgen Medtech #MedTech #Innovation #Healthcare #Asia #MedTechStartups

Solvandria Team Highlight 💼🌟📒📈👩🎓 We want to highlight a member of our Finance & Business Development team, Charlotte Wadanoli! Charlotte supported us this Summer and played a key role on organizing our finances and preparing several financial reports. She also was instrumental in developing automated trackers and data enhancements. Her input to business planning for the next year will allow Solvandria to have the necessary capital to advance our mission in support of medtech founders pursuing global health applications. Charlotte is currently a junior at Babson College where she is pursuing a business degree with a concentration on Entrepreneurship. We appreciate Charlotte's hard work and dedication to advancing global health through accelerating innovation. Thank you!

🎉 Our small but mighty Investor Catalyst Hub comms team is growing! VentureWell is hiring a Communications and Outreach Officer to support communications strategy and implementation for the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub—a groundbreaking health innovation network—as well as VentureWell’s health commercialization work. Let me know if you have any questions! ⬇

MedTech M&A Soars While IPOs and Licensing Take a Dive in 2024-What's Behind the Shift❓ Our Q2 US MedTech Industry Analysis Highlights Five Key Trends: ⭐ Venture Surge: MedTech venture funding hits $9.7 billion in H1 2024, outpacing the previous year and signalling strong growth. ⭐ M&A Momentum: 114 MedTech acquisitions in H1 2024 total $40.3 billion, nearly matching last year's impressive figures. ⭐ IPO Slowdown: MedTech IPOs remain weak with just $1.2 billion raised from three deals, reflecting a continued dip since 2021. ⭐ Modest Licensing: Licensing deals total $1.8 billion in H1 2024 with only $100 million in upfront payments, down sharply from 2023. ⭐ Smaller Rounds: Most MedTech venture investments and upfront payments are under $50 million, trending toward smaller, strategic deals. Discover what’s shaping the US MedTech world in our knowledge share series—Start with our market overview below and follow us for further insights throughout the series! Contributors - Iyappan Annamalai Subbiah Malvika Verma Miller, Ph.D. Kyle Ryder. #MedTech #HealthcareInnovation #MedTechStartups #MedTechInvesting

MedTech M&A Soars While IPOs and Licensing Take a Dive in 2024-What's Behind the Shift❓ Our Q2 US MedTech Industry Analysis Highlights Five Key Trends: ⭐ Venture Surge: MedTech venture funding hits $9.7 billion in H1 2024, outpacing the previous year and signalling strong growth. ⭐ M&A Momentum: 114 MedTech acquisitions in H1 2024 total $40.3 billion, nearly matching last year's impressive figures. ⭐ IPO Slowdown: MedTech IPOs remain weak with just $1.2 billion raised from three deals, reflecting a continued dip since 2021. ⭐ Modest Licensing: Licensing deals total $1.8 billion in H1 2024 with only $100 million in upfront payments, down sharply from 2023. ⭐ Smaller Rounds: Most MedTech venture investments and upfront payments are under $50 million, trending toward smaller, strategic deals. Discover what’s shaping the US MedTech world in our knowledge share series—Start with our market overview below and follow us for further insights throughout the series! Contributors - Iyappan Annamalai Subbiah Malvika Verma Miller, Ph.D. Kyle Ryder. #MedTech #HealthcareInnovation #MedTechStartups #MedTechInvesting

MedTech M&A Soars While IPOs and Licensing Take a Dive in 2024-What's Behind the Shift❓ Our Q2 US MedTech Industry Analysis Highlights Five Key Trends: ⭐ Venture Surge: MedTech venture funding hits $9.7 billion in H1 2024, outpacing the previous year and signalling strong growth. ⭐ M&A Momentum: 114 MedTech acquisitions in H1 2024 total $40.3 billion, nearly matching last year's impressive figures. ⭐ IPO Slowdown: MedTech IPOs remain weak with just $1.2 billion raised from three deals, reflecting a continued dip since 2021. ⭐ Modest Licensing: Licensing deals total $1.8 billion in H1 2024 with only $100 million in upfront payments, down sharply from 2023. ⭐ Smaller Rounds: Most MedTech venture investments and upfront payments are under $50 million, trending toward smaller, strategic deals. Discover what’s shaping the US MedTech world in our knowledge share series—Start with our market overview below and follow us for further insights throughout the series! Contributors - Iyappan Annamalai Subbiah Malvika Verma Miller, Ph.D. Kyle Ryder. #MedTech #HealthcareInnovation #MedTechStartups #MedTechInvesting